NGM BIOPHARMACEUTICALS INC Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q4 2021 to Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
-
Summary
-
Ngm Biopharmaceuticals Inc quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q4 2021 to Q3 2023.
- Ngm Biopharmaceuticals Inc Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2023 was $3K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)